Navigation Links
Research-based Pharmaceutical Industry and International Federation of Red Cross and Red Crescent Societies Join Forces to Prevent Non-Communicable Diseases
Date:3/18/2013

GENEVA, March 19, 2013 /PRNewswire/ --


  • Partnership is a novel cross-sector collaboration, responding to the United Nations call to tackle non-communicable diseases (NCDs)
  • Initiative goes beyond awareness-raising campaigns by prompting behavioral changes
  • Strategically combining expertise from pharmaceutical and humanitarian sectors, this initiative is expected to reach three million people

The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) and the International Federation of Red Cross and Red Crescent Societies (IFRC) announced today a partnership on NCD prevention. The two-year partnership involves support from both organizations to design a behavioral change-based toolkit that promotes healthy lifestyle choices at national and community levels. Through its volunteer network and community-based expertise, the IFRC will make the toolkit available to approximately 3 million people worldwide.

The four main NCDs- cardiovascular diseases, cancer, chronic respiratory diseases and diabetes - kill three in five people worldwide, with 80 percent of NCD-related deaths occurring in low- and middle-income countries.

Because 50 percent of NCDs are avoidable, the IFPMA-IFRC partnership enhances efforts by both organizations to combat NCDs worldwide and support IFRC community interventions to reduce the impact of these diseases locally. Since releasing its Framework for Action on NCDs in 2011, IFPMA has delivered a series of research projects and health education initiatives to identify new ways to help people fight NCDs.

"By leveraging IFRC's and IFPMA's shared goal of fighting NCDs, this novel partnership brings synergy and creativity to fighting these diseases globally," says Eduardo Pisani , IFPMA Director General.

One of IFRC's core strengths lies in community volunteers' ability to tackle the underlying social, behavioral and environmental factors that determine good health through their on-the-ground work. "Changing behaviors by eliminating shared risk factors can save lives. Red Cross Red Crescent volunteers, going door-to-door in their communities play a vital role in promoting healthy lifestyles," says Bekele Geleta , IFRC Secretary General. "But no one single player from the public or private sector working in silo can tackle the NCDs challenges. Fighting NCDs requires multi-stakeholders solutions."

About the IFPMA:

IFPMA represents the research-based pharmaceutical companies and associations across the globe. The research-based pharmaceutical industry's 1.3 million employees research, develop and provide medicines and vaccines that improve the life of patients worldwide. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health.


'/>"/>
SOURCE The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Inovio Pharmaceuticals Reports 2012 Fourth Quarter and Year End Financial Results
2. Cadence Pharmaceuticals Appoints Stephen L. Newman, M.D., to its Board of Directors
3. Isis Pharmaceuticals to Host Investor Event to Discuss ISIS-SMN Rx Data Presented at 2013 AAN Annual Meeting
4. Sagent Pharmaceuticals Selects ProspectoRx and Clinical Pharmacology
5. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Spectrum Pharmaceuticals, Inc.
6. Salix Pharmaceuticals Commits $1.125M to AGA Research Foundation
7. Peter W. Schineller Joins Alexza Pharmaceuticals as Senior Vice President and Chief Commercial Officer
8. Keryx Biopharmaceuticals Announces Appointment of Amit Sharma, M.D. as Vice President, Medical Affairs
9. Imprimis Pharmaceuticals Announces Underwriter Exercise of Over-Allotment Option
10. Isis Pharmaceuticals Reports Clinical Data Showing Blunting of Severe Increases in CRP Following Endotoxin Challenge With ISIS-CRP Rx
11. Scripps Research Institute and Takeda Pharmaceuticals Announce Expanded Research Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/6/2017)... NeuroRx, a clinical stage biopharma company developing the ... has been granted Fast Track status by the US Food ... HCl) followed by NRX-101 (D-cycloserine + lurasidone). The company will ... sequential therapy targeting patients who are admitted to Emergency Departments ... ...
(Date:9/5/2017)... , Sept. 5, 2017  Just 18 months after ... is pleased to announce the appointment of three new ... Wynne , Dominic Jones-Phillips and James ... Tammy Wynne ... of market access writers. She has over ten years, ...
(Date:8/31/2017)... , Aug. 31, 2017 PM360,s annual ... guide to the latest innovations happening across the industry. ... publication to focus on providing a comprehensive look at ... issue covers the most innovative companies, startups, divisions, products, ... "Everyone in this industry wants ...
Breaking Medicine Technology:
(Date:9/25/2017)... ... September 25, 2017 , ... Dr. Edward Hebert is celebrating ... imagine doing anything else,” said Dr. Hebert. “I count my blessings daily for the ... with my patients is what I look forward to the most. The relationships I ...
(Date:9/25/2017)... ... September 25, 2017 , ... “Grandpa's Visit”: a tender and ... share with the others. “Grandpa's Visit” is the creation of published author, Beverly Brumfield, ... is much like the character in her book. She shares, “Mr. Rice is struggling ...
(Date:9/25/2017)... ... , ... The trend-spotters, tastemakers, and healthy lifestyle product experts at the ... drinks, with the new NEXTY Gold Award at the Natural Products Expo East trade ... which is reserved for just those companies that hit high marks on the criteria ...
(Date:9/25/2017)... ... September 25, 2017 , ... Emerald Ash Borers kill Ash trees in as ... throughout the Philadelphia region. A video by Rob Nagy, ISA Certified Arborist at Giroud ... While several are dead or showing signs of decline from Emerald Ash Borers, two ...
(Date:9/24/2017)... ... ... Andrea Purcell, NMD, had an epiphany one evening. Four months pregnant, she sat sobbing at ... pregnancy was so hard. She wondered why no one talks about what it is really ... she decided to write what she wished her friends and colleagues could have told her: ...
Breaking Medicine News(10 mins):